Brief: Rovi Completes Strategic Review Of Its CDMO Business

Laboratorios Farmaceuticos Rovi

24/10/2024 06:54

Oct 24 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * COMPLETES THE STRATEGIC REVIEW OF ITS CDMO BUSINESS
    * BEST WAY TO MAXIMIZE VALUE FOR SHAREHOLDERS AT THIS TIME
IS TO
CONTINUE EXECUTING ON COMPANY’S STANDALONE STRATEGIC PLAN

Source text for Eikon:  ID:nCNMbDnfqM 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))